Chart Review and Exploration of Sustaining Remission in Major Depressive Disorder

 For For patients with major depressive disorder (MDD), achieving remission is the penultimate therapeutic goal. Still, many patients treated with the standard initial treatment do not achieve a full and durable response. Rather, they are at high risk for residual and recurrent symptoms, treatment-resistance, and relapse.1 This neuroscienceCME Chart Review activity addresses clinician-based gaps that may contribute to suboptimal rates of long-term, sustained remission among patients with MDD. Specifically, an index patient case will be used as the content foundation upon which expert faculty will engage in a provocative, consult-type exchange. 

As participants, clinicians will benefit from a robust discussion of the clinical decisions and course of the index patient that ”folds in” recommendations from treatment guidelines,2 data from well-controlled studies,3 and pearls from national and international experts. Consider it a medical soap opera and join us!

Join us on December 1 for this free neuroscienceCME activity on major depressive disorder.